Showing results (11-20 of 130) with videos related to
Sort By:
Pageof 13
Advances in Chronic Kidney Disease|October 16, 2016
Costimulatory Blockade and Use of mTOR Inhibitors: Avoiding Injury Part 2David Wojciechowski, Flavio VincentiCurrent Opinion in Organ Transplantation|October 6, 2011
Targeting JAK3 in kidney transplantation: current status and future optionsDavid Wojciechowski, Flavio VincentiSeminars in Immunology|August 23, 2011
Challenges and opportunities in targeting the costimulation pathway in solid organ transplantationDavid Wojciechowski, Flavio VincentiCurrent Opinion in Organ Transplantation|October 9, 2010
How the development of new biological agents may help minimize immunosuppression in kidney transplantation: the impact of belataceptDavid Wojciechowski, Flavio VincentiExpert Opinion on Investigational Drugs|July 12, 2013
Tofacitinib in kidney transplantationDavid Wojciechowski, Flavio VincentiCurrent Opinion in Organ Transplantation|October 10, 2012
Belatacept in kidney transplantationDavid Wojciechowski, Flavio VincentiAmerican Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 9, 2024
Antiplasma cell antibodies: A new era of human leukocyte antigen antibody control in solid organ transplantationSindhu Chandran, Flavio VincentiAnnual Review of Medicine|October 6, 2006
T cell costimulation: a rational target in the therapeutic armamentarium for autoimmune diseases and transplantationFlavio Vincenti, Michael LuggenSeminars in Liver Disease|July 20, 2006
Immunosuppression: today, tomorrow, and withdrawalRyutaro Hirose, Flavio VincentiCold Spring Harbor Perspectives in Medicine|December 28, 2013
Clinical aspects: focusing on key unique organ-specific issues of renal transplantationSindhu Chandran, Flavio VincentiPageof 13